Current treatment options for tremor, the most common movement disorder, are quite poor. Discontinuation of compliance to oral medications is due to significant side effects and no noticeable benefit in tremor severity. Botulinim toxin type A is a recognized tremor therapy however, adverse events and the inability of Movement Disorder Neurologists to visually locate these […]
Read More